+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07901387

Biomarker-Based Diagnosis and Treatment Monitoring of Extrapulmonary Tuberculosis in Nairobi, Kenya

Led by Nagasaki University · Updated on 2026-10-28

700

Participants Needed

2

Research Sites

73 weeks

Total Duration

AI-Summary

What This Trial Is About

Tuberculosis TB remains a major global health challenge, especially in regions like Africa where the incidence is high. Extrapulmonary TB EPTB accounts for a significant portion of cases, particularly in areas with high HIV rates. Current diagnostic methods often struggle to detect EPTB due to the low number of bacteria present, which leads to delays or missed diagnoses and increases risks for affected patients. This study focuses on improving diagnosis and treatment monitoring for EPTB using biomarker-based methods in Nairobi, Kenya. The study will use biomarkers such as lipoarabinomannan LAM, MPT64, and Ag85B to develop more sensitive, non-invasive diagnostic tests. Techniques like ultrasensitive enzyme-linked immunosorbent assays ELISA and urine concentration methods will be employed to enhance detection accuracy. The study will enroll 763 adult patients suspected of having EPTB along with 150 control participants. For confirmed EPTB cases, follow-up samples will be collected during treatment to observe biomarker changes and treatment progress. Participants will provide clinical and demographic information along with sputum, blood, and urine samples at enrollment. These samples will be tested to assess the accuracy of the biomarkers compared to standard diagnostic methods. For those with confirmed EPTB, additional samples will be collected during treatment to monitor responses. The study aims to produce diagnostic tools suitable for resource-limited settings and to clarify the presence of non-tuberculosis mycobacteria and fungal infections, helping to guide better patient care in high-burden areas.

CONDITIONS

Brief Title

Biomarker Analysis for Diagnosing and Treatment Monitoring in Extrapulmonary Tuberculosis Patients in Nairobi, Kenya

Research Team

N

Nobuo Saito, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here